Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Inconsistencies in dosage practice in children with overweight or obesity: A retrospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical trial allocation in multinational pharmaceutical companies - a qualitative study on influential factors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Mechanical and vasomotor properties of piglet isolated middle cerebral artery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Biased small-molecule ligands for selective inhibition of HIV-1 cell entry via CCR5

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Urinary markers of nucleic acid oxidation increase with age, obesity and insulin resistance in Danish children and adolescents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Obesity can affect the pharmacokinetics of most drugs, which may result in under- or overdosing if traditional pediatric dosing strategies are used. To investigate currently applied dosage strategies in children with overweight or obesity (overweight/obesity), in a clinical treatment facility. In particular, whether dosing guidelines were available and metrics of body size applied. A retrospective cohort study of 200 patients admitted to the Danish Children's Obesity Clinic. Data were collected from 2007 to 2015. Overweight/obese children 3-18 years were included if they had at least one drug prescription. Overall there were 658 prescriptions, primarily analgesics, psychotropics, asthma medications, and antibiotics. Except for one prescription, guidelines for dosage of overweight/obese children were not available in the clinic. In one prescription of gentamicin, the dose was adjusted by a metric body size. Otherwise dose was predominately prescribed either by total body weight or as fixed dose by age, in accordance with the recommendations of normal weight children. In drugs with a narrow therapeutic interval, we found large interindividual variations in dosing regimens, that is, for gentamicin, paracetamol, and prednisolone. Reduction of dose to the maximum recommended adult dose was common practice, when the dose calculated by total body weight (ie, mg/kg) exceeded this maximum. This study highlights the shortage of dosing guidelines in overweight/obese children. We found a large interindividual variability in dosage regimens, even in drugs with narrow therapeutic intervals. The clinicians rely on "best practice", as evidence-based dosage regimens are missing for many drugs prescribed during childhood.

OriginalsprogEngelsk
TidsskriftPharmacology Research & Perspectives
Vol/bind6
Udgave nummer3
Sider (fra-til)e00398
ISSN2052-1707
DOI
StatusUdgivet - jun. 2018

ID: 55664240